Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rachlis

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
International Journal of STD & AIDS|December 4, 2008
Is there a reservoir of sub-clinical lymphogranuloma venereum and non-LGV Chlamydia trachomatis infection in men who have sex with men?J Tinmouth, M W Gilmour, C Kovacs, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|December 9, 2010
Virologic and immunologic effectiveness of tipranavir/ritonavir (TPV/r)- versus darunavir/ritonavir (DRV/r)-based regimens in clinical practiceTony Antoniou, J M Raboud, C Diong, et al.
The New England Journal of Medicine|December 22, 1999
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 TeamS Staszewski, J Morales-Ramirez, K T Tashima, et al.
Antiviral Research|January 2, 2007
Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtideM R Loutfy, J M Raboud, J S G Montaner, et al.
HIV Medicine|September 1, 2007
A large prospective study assessing injection site reactions, quality of life and preference in patients using the Biojector vs standard needles for enfuvirtide administrationM R Loutfy, M Harris, J M Raboud, et al.
HIV Medicine|July 8, 2016
Quality of initial HIV care in Canada: extension of a composite programmatic assessment tool for HIV therapyS Kesselring, A Cescon, G Colley, et al.
HIV Medicine|November 10, 2010
Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohortA M Cescon, C Cooper, K Chan, et al.
AIDS Research and Human Retroviruses|May 5, 1998
Active immunization of patients with HIV infection: a study of the effect of VaxSyn, a recombinant HIV envelope subunit vaccine, on progression of immunodeficiencyC M Tsoukas, J Raboud, N F Bernard, et al.
HIV Medicine|November 16, 2018
Late diagnosis, delayed presentation and late presentation among persons enrolled in a clinical HIV cohort in Ontario, Canada (1999-2013)J Wilton, L Light, S Gardner, et al.
European Journal of Clinical Nutrition|May 25, 2006
A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndromeJ Austin, N Singhal, R Voigt, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
International Journal of STD & AIDS|December 4, 2008
Is there a reservoir of sub-clinical lymphogranuloma venereum and non-LGV Chlamydia trachomatis infection in men who have sex with men?J Tinmouth, M W Gilmour, C Kovacs, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|December 9, 2010
Virologic and immunologic effectiveness of tipranavir/ritonavir (TPV/r)- versus darunavir/ritonavir (DRV/r)-based regimens in clinical practiceTony Antoniou, J M Raboud, C Diong, et al.
The New England Journal of Medicine|December 22, 1999
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 TeamS Staszewski, J Morales-Ramirez, K T Tashima, et al.
Antiviral Research|January 2, 2007
Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtideM R Loutfy, J M Raboud, J S G Montaner, et al.
HIV Medicine|September 1, 2007
A large prospective study assessing injection site reactions, quality of life and preference in patients using the Biojector vs standard needles for enfuvirtide administrationM R Loutfy, M Harris, J M Raboud, et al.
HIV Medicine|July 8, 2016
Quality of initial HIV care in Canada: extension of a composite programmatic assessment tool for HIV therapyS Kesselring, A Cescon, G Colley, et al.
HIV Medicine|November 10, 2010
Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohortA M Cescon, C Cooper, K Chan, et al.
AIDS Research and Human Retroviruses|May 5, 1998
Active immunization of patients with HIV infection: a study of the effect of VaxSyn, a recombinant HIV envelope subunit vaccine, on progression of immunodeficiencyC M Tsoukas, J Raboud, N F Bernard, et al.
HIV Medicine|November 16, 2018
Late diagnosis, delayed presentation and late presentation among persons enrolled in a clinical HIV cohort in Ontario, Canada (1999-2013)J Wilton, L Light, S Gardner, et al.
European Journal of Clinical Nutrition|May 25, 2006
A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndromeJ Austin, N Singhal, R Voigt, et al.
Pageof 6